MyAverix Finance
LSE · Healthcare
Thalia Therapeutics Plc (THAT)
Biotechnology
Thalia Therapeutics Plc (THAT) is listed on LSE in the Healthcare sector. Industry: Biotechnology. As of 2026-05-21, reported market cap is $5.93M, P/E ratio is 25.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for THAT
Thalia Therapeutics Plc (THAT) — FAQ
What is Thalia Therapeutics Plc's market cap?
Thalia Therapeutics Plc (THAT) has a reported market cap of $5.93M (data as of 2026-05-21).
What is THAT's P/E ratio?
The price-to-earnings (P/E) ratio for Thalia Therapeutics Plc (THAT) is 25.00 (data as of 2026-05-21).
Does Thalia Therapeutics Plc pay a dividend?
Dividend yield is not available in the current snapshot for Thalia Therapeutics Plc (THAT). Check the MyAverix Finance app for the latest dividend data.
What sector is Thalia Therapeutics Plc in?
Thalia Therapeutics Plc (THAT) is classified in the Healthcare sector (Biotechnology industry).
What exchange is THAT listed on?
THAT is listed on LSE.
What is Thalia Therapeutics Plc's net margin?
Thalia Therapeutics Plc (THAT) reports a net margin of 0.0% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.